DE69931814D1 - Umwandlung von cox-inhibierenden, nicht cox-2 selektiven inhibitoren in derivate von cox-2 selektiven inhibitoren - Google Patents

Umwandlung von cox-inhibierenden, nicht cox-2 selektiven inhibitoren in derivate von cox-2 selektiven inhibitoren

Info

Publication number
DE69931814D1
DE69931814D1 DE69931814T DE69931814T DE69931814D1 DE 69931814 D1 DE69931814 D1 DE 69931814D1 DE 69931814 T DE69931814 T DE 69931814T DE 69931814 T DE69931814 T DE 69931814T DE 69931814 D1 DE69931814 D1 DE 69931814D1
Authority
DE
Germany
Prior art keywords
cox
selective inhibitors
derivatives
inhibited
conversion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69931814T
Other languages
English (en)
Other versions
DE69931814T2 (de
Inventor
S Kalgutkar
J Marnett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of DE69931814D1 publication Critical patent/DE69931814D1/de
Application granted granted Critical
Publication of DE69931814T2 publication Critical patent/DE69931814T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69931814T 1999-01-07 1999-12-16 Umwandlung von cox-inhibierenden, nicht cox-2 selektiven inhibitoren in derivate von cox-2 selektiven inhibitoren Expired - Lifetime DE69931814T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11509099P 1999-01-07 1999-01-07
US115090P 1999-01-07
PCT/US1999/030219 WO2000040087A1 (en) 1999-01-07 1999-12-16 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors

Publications (2)

Publication Number Publication Date
DE69931814D1 true DE69931814D1 (de) 2006-07-20
DE69931814T2 DE69931814T2 (de) 2007-01-04

Family

ID=22359275

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69931814T Expired - Lifetime DE69931814T2 (de) 1999-01-07 1999-12-16 Umwandlung von cox-inhibierenden, nicht cox-2 selektiven inhibitoren in derivate von cox-2 selektiven inhibitoren

Country Status (11)

Country Link
EP (1) EP1148783B1 (de)
JP (1) JP2002534361A (de)
CN (1) CN1227008C (de)
AT (1) ATE328593T1 (de)
AU (1) AU772705B2 (de)
BR (1) BR9917001A (de)
CA (1) CA2358241A1 (de)
DE (1) DE69931814T2 (de)
ES (1) ES2270634T3 (de)
IL (1) IL144126A0 (de)
WO (1) WO2000040087A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030346A1 (es) 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico
US6646003B2 (en) 2001-04-02 2003-11-11 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
FR2835433B1 (fr) * 2002-02-01 2006-02-17 Richard Lab M Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2
JP4354984B2 (ja) 2003-05-07 2009-10-28 オステオロジックス エイ／エス 水溶性ストロンチウム塩を用いる軟骨／骨症状の治療
WO2005002525A2 (en) * 2003-07-01 2005-01-13 Microbia, Inc. Cox-2 and faah inhibitors
EP1744747A4 (de) 2004-04-26 2009-12-02 Univ Vanderbilt Indolessigsäure und indolessigsäurederivate als therapeutische wirkstoffe mit verminderter gastrointestinaler toxizität
WO2007149456A2 (en) 2006-06-19 2007-12-27 Vanderbilt University Methods and compositions for diagnostic and therapeutic targeting of cox-2
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3336194A (en) * 1963-04-30 1967-08-15 Merck & Co Inc Indolyl acid amides
US3285908A (en) * 1963-04-30 1966-11-15 Merck & Co Inc Indolyl acid amides
FR2358145A1 (fr) 1976-03-29 1978-02-10 Richard Sa Laboratoire M Nouveau medicament anti-inflammatoire, analgesique et antipyretique a base de (p-chlorobenzoyl-1 methyl-2 methoxy-5)-indole-3 acetate de p-acetamidophenol
JPS5872560A (ja) * 1981-10-27 1983-04-30 Teikoku Chem Ind Corp Ltd インドメタシンフエニルエステル誘導体
JPS60152462A (ja) * 1984-01-20 1985-08-10 Terumo Corp インド−ル酢酸アミド誘導体の製造方法
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs

Also Published As

Publication number Publication date
EP1148783A4 (de) 2003-05-21
CA2358241A1 (en) 2000-07-13
IL144126A0 (en) 2002-05-23
CN1227008C (zh) 2005-11-16
ATE328593T1 (de) 2006-06-15
AU772705B2 (en) 2004-05-06
ES2270634T3 (es) 2007-04-01
BR9917001A (pt) 2001-11-13
JP2002534361A (ja) 2002-10-15
WO2000040087A1 (en) 2000-07-13
AU2369700A (en) 2000-07-24
CN1337851A (zh) 2002-02-27
DE69931814T2 (de) 2007-01-04
EP1148783A1 (de) 2001-10-31
EP1148783B1 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
BR9804214A (pt) Compostos.
BR9900177A (pt) Inibidores de metaloprotease.
DZ3186A1 (fr) Ptéridinones utilisées comme inhibiteurs de kinase.
EA199900837A1 (ru) Способ применения ингибиторов циклооксигеназы-2 для предупреждения сердечно-сосудистых расстройств
PT1193270E (pt) Pirrolobenzodiazepinas
EA200100688A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОБИЦИКЛЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa
NO20025590D0 (no) Fenylglycin-derivater
ID27838A (id) Inhibitor 1,2,3,4-tetrahidrokinolin tersubstitusi 2-tersubstitusi 4-amino sebagai inhibitor cetp
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
EA199900373A2 (ru) Фармацевтические композиции
DE69906311D1 (de) Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren
ATE302775T1 (de) Carbolinderivate
NO20003451D0 (no) 2,3-substituerte indolforbindelser som cox-2 inhibitorer
DE602004022415D1 (de) Pyrrolo-dihydroisochinolin-derivate als pde10-inhibitoren
SE0103710D0 (sv) Compounds
DE69931814D1 (de) Umwandlung von cox-inhibierenden, nicht cox-2 selektiven inhibitoren in derivate von cox-2 selektiven inhibitoren
EA200200381A1 (ru) Тетрагидротиопиранфталазиноновые производные в качестве ингибиторов pde4
EA200100854A1 (ru) Кальций-литические соединения
NO20050019L (no) Polytylenglykolaldehyd-derivater
ATE259813T1 (de) Triazolopyrimidinderivate
MY128164A (en) Compounds
AP2001002045A0 (en) FKBP inhibitors.
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
EP1476149A4 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition